73
Participants
Start Date
September 8, 2020
Primary Completion Date
March 23, 2023
Study Completion Date
March 23, 2023
Bomedemstat
Oral administration
Local Institution, St Leonards
Local Institution, Clayton
Royal Adelaide Hospital, Adelaide
Local Institution, New York
Local Institution, Pittsburgh
Local Institution, Durham
Local Institution, Jacksonville
Cleveland Clinic, Cleveland
Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ), Essen
Local Institution, Ann Arbor
CRIMM; Centro Ricerca e Innovazione delle Malattia Mieloproliferative, Azienda ospedaliera Universitaria Careggi, Florence
Local Institution, Seattle
Local Institution, Herston
Local Institution, Camperdown
Local Institution, Southport
Local Institution, Jena
Local Institution, Hong Kong
Local Institution, Alessandria
Local Institution, Bologna
Local Institution, Varese
Local Institution, Auckland
Middlemore Hospital, Auckland
Local Institution, Oxford
Local Institution, London
Guys and St Thomas Hospital, London
Local Institution, London
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
INDUSTRY